Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

476
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
476
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.2K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.2K
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

894
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
894
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

577
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
577
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Sources and transmission dynamics of Campylobacter and Shigella using culture-independent molecular methods in Tanzania (SCAT): a protocol for a prospective observational cohort study.

medRxiv : the preprint server for health sciences·2026
Same author

The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study.

EClinicalMedicine·2026
Same author

Human-milk vitamin B-3 (niacin and vitamer) concentrations: secondary analysis of a randomized, placebo-controlled trial of maternal nicotinamide supplementation in rural Tanzania.

The American journal of clinical nutrition·2026
Same author

Kinetics of Enteric Pathogen Quantity During Acute Diarrhea in Children in Resource-Limited Settings.

Open forum infectious diseases·2026
Same author

Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.

PLoS neglected tropical diseases·2026
Same author

Impact of Azithromycin Administration at Hospital Discharge on Antimicrobial Resistance and Enteropathogen Carriage 3 Months Following Treatment.

medRxiv : the preprint server for health sciences·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Feb 16, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K

La shigelosis

Karen L Kotloff1, Mark S Riddle2, James A Platts-Mills3

  • 1Departments of Pediatrics and Medicine, Center for Vaccine Development, Institute for Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Lancet (London, England)
|December 20, 2017
PubMed
Resumen
Este resumen es generado por máquina.

La shigelosis, una enfermedad diarreica grave, causa una mortalidad significativa en todo el mundo, especialmente en niños pequeños. La emergente resistencia a los antibióticos requiere nuevos tratamientos y el desarrollo de vacunas para combatir esta amenaza infecciosa.

Más Videos Relacionados

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K
A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K

Videos de Experimentos Relacionados

Last Updated: Feb 16, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K
Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K
A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K

Área de la Ciencia:

  • Enfermedades infecciosas
  • Microbiología
  • Salud pública

Sus antecedentes:

  • La shigelosis es una infección intestinal grave causada por la especie Shigella.
  • Afecta desproporcionadamente a los niños pequeños en entornos de bajos ingresos, causando una carga sustancial de enfermedades.
  • Las manifestaciones van desde la diarrea hasta la disentería grave con posibles complicaciones.

Objetivo del estudio:

  • Para resumir la carga global de la shigelosis.
  • Para resaltar las amenazas emergentes como la resistencia a los antimicrobianos.
  • Para discutir la necesidad de nuevas intervenciones, incluidas las vacunas.

Principales métodos:

  • Revisión de la literatura y síntesis de los datos epidemiológicos.
  • Análisis de las manifestaciones y complicaciones clínicas.
  • Revisión de las recomendaciones actuales de tratamiento y estado de desarrollo de la vacuna.

Principales resultados:

  • La shigelosis causa unas 164.000 muertes anuales en todo el mundo.
  • Las cepas de Shigella multirresistentes se están extendiendo internacionalmente.
  • Varios candidatos a la vacuna Shigella se encuentran en ensayos clínicos.

Conclusiones:

  • La shigelosis sigue siendo un gran problema de salud mundial, especialmente en las poblaciones vulnerables.
  • La resistencia a los antimicrobianos plantea un desafío significativo para el tratamiento.
  • El desarrollo de vacunas es crucial para controlar la transmisión de la shigelosis y reducir la mortalidad.